Sime Darby Oils (SDO) collaborated via a memorandum of agreement withUniversiti Kebangsaan Malaysia (UKM) to begin the world’s first clinical trial todetermine tocotrienols which is derived from palm oil could be used as atherapeutic approach for the treatment of non-alcoholic fatty liver disease(NAFLD). The parties are expecting to see preliminary results within six months fromthe commencement of the clinical trial this month and a full publication of thefindings in 2021.
